ReviewDietary phytochemicals as epigenetic modifiers in cancer: Promise and challenges
Introduction
The term ‘Epigenetics’ was coined by British developmental biologist Conrad Waddington, derived from the combination of word ‘epigenesis’ and ‘genetics’ [1]. Epigenetics is defined as the branch of biology which studies the casual interactions between genes and their products, where ‘Epi’ means above or over and ‘genetics’ reflects the involvement of genes and heredity. Today epigenetics may be defined as the study of chemical changes to the genome that are heritable and modulate gene expression or cellular phenotype through mechanisms involving how DNA is packaged and expressed without any alterations in the gene nucleotide sequence itself [1], [2]. Epigenetic mechanisms have been shown to be essential in regulating normal cellular functions and play important role during developmental stages. In mammals, DNA methylation is associated with several key processes such as genomic imprinting, X-chromosome inactivation and tissue-specific gene expression [3], [4], [5], [6]. Histone methylation and acetylation patterns were demonstrated to be closely associated with cognitive functions such as long term memory formation and storage [7], [8], [9]. Epigenetic alterations have been implicated in several pathologies such as cancer, metabolic syndrome, Alzheimer’s disease and other neurological disorders [10], [11], [12], [13]. Unlike genetic changes in the genome such as mutation, epigenetic modifications are potentially reversible and can be modified by environmental, dietary and lifestyle factors. Epigenetic mechanisms have been implicated in physiological responses to intrinsic and extrinsic environmental stimuli such as nutrition, radiation, exposure to chemicals, toxins and hormones [14], [15]. The epigenetic diet, or the control of epigenetic modifiers through consumption of dietary phytochemicals, is of extreme interest. Several studies suggest that dietary phytochemicals are not only an essential source of nutrients but also important in the elimination of cancer as a life-threatening disease [14], [15]. In this review, we focused on the role of dietary phytochemicals as epigenetic modifiers. We discussed in detail different mechanisms of epigenetic modifications in mammals and present a comprehensive overview of the current state of knowledge on dietary bioactive compounds and their influence on various epigenetic mechanisms highlighting their role as potential anticancer agents.
Section snippets
Mechanisms of epigenetic modifications
Although a number of epigenetic mechanisms have now been identified, in mammals there are three major epigenetic mechanisms which are known to regulate gene expression. These include DNA methylation, alteration of chromatin structure by post-translational modification of histone or non-histone proteins, and small non-coding microRNAs (miRNAs) that modulate gene expression by either inhibiting translation or causing targeted degradation of specific mRNAs [15], [16].
Epigenetic mechanisms regulated by dietary phytochemicals
Unlike genetic modifications, epigenetic states of genes are reversible and can be altered by certain intrinsic and extrinsic factors. This characteristic of epigenetic mechanism may lead to the development of abnormal phenotype as well as regulate physiological response to some environmental stimuli, diet or therapeutic intervention [15]. In past two decades, accumulated evidences show that dietary phytochemicals present in abundance in fruits, vegetables and beverages which were earlier known
Conclusion, limitation and future direction
The role of dietary phytochemicals as epigenetic modifiers has been well supported by the studies described herein holding great promise in cancer prevention and/or therapy. In addition, this review article provides a comprehensive summary on dietary phytochemicals with potential beneficial effects may in part be attributable to their epigenetic properties, including changes in DNA methylation patterns, histone modifications, and in the expression of miRNAs (Fig. 1). The fundamental role of
Conflict of interest
The authors have no competing interest.
Acknowledgements
The original work from author’s laboratory outlined in this review was supported by VA Merit Review 1I01BX002494 and from the United States Public Health Service Grants RO1CA108512, R21CA193080 and R03CA186179 to SG.
References (258)
- et al.
Exploring and explaining epigenetic effects
Trends Genet.
(1997) - et al.
The role of histone acetylation in age-associated memory impairment and Alzheimer’s disease
Neurobiol. Learn Mem.
(2011) - et al.
Cancer chemoprevention by dietary polyphenols: promising role for epigenetics
Biochem. Pharmacol.
(2010) - et al.
On the mechanism of inhibition of DNA-cytosine methyltransferases by cytosine analogs
Cell
(1983) - et al.
DNA (cytosine-5)-methyltransferases in mouse cells and tissues: studies with a mechanism-based probe
J. Mol. Biol.
(1997) - et al.
DNA methyltransferases Dnmt3a and Dnmt3b are essential for de novo methylation and mammalian development
Cell
(1999) - et al.
Effects of DNA methylation on DNA-binding proteins and gene expression
Curr. Opin. Genet Dev.
(1993) - et al.
Biological implications and therapeutic significance of DNA methylation regulated genes in cervical cancer
Biochimie
(2016) - et al.
DNA methylation, histone acetylation and methylation of epigenetic modifications as a therapeutic approach for cancers
Cancer Lett.
(2016) - et al.
The histone tails of the nucleosome
Curr. Opin Genet Dev.
(1998)
Twenty-five years of the nucleosome, fundamental particle of the eukaryote chromosome
Cell
Histone methylation versus histone acetylation: new insights into epigenetic regulation
Curr. Opin. Cell Biol.
Circulating autoantibodies in cancer patients have high specificity for glycoxidation modified histone H2A
Clin. Chim. Acta.
Chromatin modifications and their function
Cell
Non-coding RNAs, epigenetics and complexity
Gene
A new frontier for molecular medicine: noncoding RNAs
Biochim. Biophys. Acta
MYC stimulates EZH2 expression by repression of its negative regulator miR-26a
Blood
Mir-214-dependent regulation of the polycomb protein Ezh2 in skeletal muscle and embryonic stem cells
Mol. Cell.
miR-200c inhibits melanoma progression and drug resistance through down-regulation of BMI-1
Am. J. Pathol.
lncRNAs and microRNAs with a role in cancer development
Biochim. Biophys. Acta
MicroRNA-29b induces global DNA hypomethylation and tumor suppressor gene reexpression in acute myeloid leukemia by targeting directly DNMT3A and 3B and indirectly DNMT1
Blood
Dietary agents in cancer prevention: flavonoids and isoflavonoids
Pharmacol. Ther.
Polyphenols: food sources and bioavailability
Am. J. Clin. Nutr.
Effects of C-glycosylation on anti-diabetic, anti-Alzheimer's disease and anti-inflammatory potential of apigenin
Food Chem. Toxicol.
Curcumin a component of golden spice: from bedside to bench and back
Biotechnol. Adv.
Curcumin: the story so far
Eur. J. Cancer.
Curcumin is a potent DNA hypomethylation agent
Bioorg Med. Chem. Lett.
Molecular modifications on carboxylic acid derivatives as potent histone deacetylase inhibitors: activity and docking studies
Bioorg Med. Chem.
Histone acetyl transferases as emerging drug targets
Drug Discov. Today
Curcumin, a novel p300/CREB-binding protein-specific inhibitor of acetyltransferase, represses the acetylation of histone/nonhistone proteins and histone acetyltransferase-dependent chromatin transcription
J. Biol. Chem.
Epigenetics: the sins of the father
Nature
X chromosome dosage compensation: how mammals keep the balance
Annu. Rev. Genet.
A novel CpG island set identifies tissue-specific methylation at developmental gene loci
PLoS Biol.
Role for DNA methylation in genomic imprinting
Nature
The role of DNA methylation in mammalian epigenetics
Science
Histone lysine methylation: critical regulator of memory and behavior
Rev. Neurosci.
The role of histone acetylation in memory formation and cognitive impairments
Neuropsychopharmacology
Epigenetic mechanisms: critical contributors to long-term memory formation
Neuroscientist
Epigenetic mechanisms of gene expression regulation in neurological diseases
Acta Neurobiol. Exp. (Wars)
The fundamental role of epigenetic events in cancer
Nat. Rev. Genet.
Epigenetic priming of the metabolic syndrome
Toxicol Mech Methods
Environmental influences on epigenetic profiles
Semin. Reprod. Med.
Epigenetic regulation of gene expression: how the genome integrates intrinsic and environmental signals
Nat. Genet.
From Waddington’s epigenetic landscape to small noncoding RNA: some important milestones in the history of epigenetics research
Toxicol. Mech. Methods
Targeting DNA methylation
Clin. Cancer Res.
DNA methylation and cancer diagnosis: new methods and applications
Exp. Rev. Mol. Diagn.
Cancer chemoprevention and nutriepigenetics: state of the art and future challenges
Top Curr. Chem.
The DNA methyltransferases of mammals
Hum. Mol. Genet.
DNA methylation patterns and epigenetic memory
Genes Dev.
Dnmt3L and the establishment of maternal genomic imprints
Science
Cited by (117)
Connecting the dots in the associations between diet, obesity, cancer, and microRNAs
2023, Seminars in Cancer BiologyTargeting DNA methyltransferases in non-small-cell lung cancer
2022, Seminars in Cancer BiologyCitation Excerpt :According to different studies, regular intake of these fruits, vegetables, or supplements that have phytochemicals may be useful in preventing or controlling different types of cancer [106–111]. Also, dietary phytochemicals could modulate the epigenetic mechanisms including DNA methylation, histone modification, and non-coding RNAs [112–114]. Genistein, Resveratrol, Polyphenols, and different types of fatty acids are an example of nutrients that have positive effects on health; they are further studied as protective factors against cancer, cardiovascular disease and obesity through understanding their epigenetic mechanisms [115].
Updated review on green tea polyphenol epigallocatechin-3-gallate as a cancer epigenetic regulator
2022, Seminars in Cancer BiologyProgress and promises of epigenetic drugs and epigenetic diets in cancer prevention and therapy: A clinical update
2022, Seminars in Cancer Biology